Iovino, F.; Diana, A.; Carlino, F.; Ferraraccio, F.; Antoniol, G.; Fisone, F.; Perrone, A.; Zito Marino, F.; Panarese, I.; Tathode, M.S.;
et al. Expression of c-MET in Estrogen Receptor Positive and HER2 Negative Resected Breast Cancer Correlated with a Poor Prognosis. J. Clin. Med. 2022, 11, 6987.
https://doi.org/10.3390/jcm11236987
AMA Style
Iovino F, Diana A, Carlino F, Ferraraccio F, Antoniol G, Fisone F, Perrone A, Zito Marino F, Panarese I, Tathode MS,
et al. Expression of c-MET in Estrogen Receptor Positive and HER2 Negative Resected Breast Cancer Correlated with a Poor Prognosis. Journal of Clinical Medicine. 2022; 11(23):6987.
https://doi.org/10.3390/jcm11236987
Chicago/Turabian Style
Iovino, Francesco, Anna Diana, Francesca Carlino, Franca Ferraraccio, Giuliano Antoniol, Francesca Fisone, Alessandra Perrone, Federica Zito Marino, Iacopo Panarese, Madhura S. Tathode,
and et al. 2022. "Expression of c-MET in Estrogen Receptor Positive and HER2 Negative Resected Breast Cancer Correlated with a Poor Prognosis" Journal of Clinical Medicine 11, no. 23: 6987.
https://doi.org/10.3390/jcm11236987
APA Style
Iovino, F., Diana, A., Carlino, F., Ferraraccio, F., Antoniol, G., Fisone, F., Perrone, A., Zito Marino, F., Panarese, I., Tathode, M. S., Caraglia, M., Gatta, G., Ruggiero, R., Parisi, S., De Vita, F., Ciardiello, F., Docimo, L., & Orditura, M.
(2022). Expression of c-MET in Estrogen Receptor Positive and HER2 Negative Resected Breast Cancer Correlated with a Poor Prognosis. Journal of Clinical Medicine, 11(23), 6987.
https://doi.org/10.3390/jcm11236987